Found: 6
Select item for more details and to access through your institution.
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 16, p. 2059, doi. 10.3390/cells12162059
- By:
- Publication type:
- Article
DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1100, doi. 10.3390/cells12071100
- By:
- Publication type:
- Article
Calorie Restriction Impairs Anti-Tumor Immune Responses in an Immunogenic Preclinical Cancer Model.
- Published in:
- Nutrients, 2023, v. 15, n. 16, p. 3638, doi. 10.3390/nu15163638
- By:
- Publication type:
- Article
Evaluation of immune-mediated idiosyncratic drug toxicity using chimeric HLA transgenic mice.
- Published in:
- Archives of Toxicology, 2018, v. 92, n. 3, p. 1177, doi. 10.1007/s00204-017-2112-9
- By:
- Publication type:
- Article
Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02657-2
- By:
- Publication type:
- Article
An Animal Model of Abacavir-Induced HLA-Mediated Liver Injury.
- Published in:
- Toxicological Sciences, 2018, v. 162, n. 2, p. 713, doi. 10.1093/toxsci/kfy001
- By:
- Publication type:
- Article